Evaluation and management of acquired methemoglobinemia associated with topical benzocaine use

Am J Cardiovasc Drugs. 2013 Oct;13(5):325-30. doi: 10.1007/s40256-013-0027-2.

Abstract

Benzocaine is a widely used topical oropharyngeal anesthetic and has been reported to cause methemoglobinemia. We discuss benzocaine-induced methemoglobinemia and review the causes, presentation, and management of this serious complication. Treatment with methylene blue will result in reversal of methemoglobinemia and clinical recovery in most cases but needs to be used at appropriate doses in carefully selected individuals. Physicians who perform procedures involving the application of benzocaine for topical anesthesia need to rapidly identify and treat methemoglobinemia to avoid significant associated morbidity and mortality.

Publication types

  • Review

MeSH terms

  • Administration, Topical
  • Anesthetics, Local / administration & dosage
  • Anesthetics, Local / adverse effects*
  • Benzocaine / administration & dosage
  • Benzocaine / adverse effects*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Methemoglobinemia / chemically induced*
  • Methemoglobinemia / diagnosis
  • Methemoglobinemia / drug therapy
  • Methylene Blue / administration & dosage
  • Methylene Blue / therapeutic use
  • Patient Selection

Substances

  • Anesthetics, Local
  • Enzyme Inhibitors
  • Methylene Blue
  • Benzocaine